CPhI Worldwide

Short-Term Reshoring

The second part of the 2021 CPhI Annual Report looks ahead to predict the pharma manufacturing, therapeutic and technology environment in 2030.

Topics • Strategy

CPhI Worldwide Returns to Madrid

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

API Manufacturing

Easyfairs Deutschland GmbH

Leading the way. Driving results.

Sasol

Leading Transformation

Nova-Institut GmbH

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Dow Chemical Company

Anchored in Sustainability

Brenntag SE

Brenntag Downsizes Management Board, Retains Both Divisions

Concept Heidelberg

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Together for Sustanability (TFS)

Driving Sustainability Through Collaboration

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Interview

The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Impress PR

Informa Markets

CPhI Worldwide

Short-Term Reshoring

Patient Centricity: The New Nexus for CDMOs

CPhI Worldwide Announces International Advisory Board

CPhI Announces Founding Members of Expert Industry Panel

CPhI, PharmaEvolution to Analyze Pharma Industry in Monthly and Annual Reports

CPhI Worldwide Returns to Madrid

Top-Feature

API Manufacturing

Leading the way. Driving results.

Leading Transformation

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Anchored in Sustainability

Brenntag Downsizes Management Board, Retains Both Divisions

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Driving Sustainability Through Collaboration

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Interview

Leading Transformation

Newsletter & e-edition